The Cambridge, Mass.-based drugmaker did not specify a projected timeline for when the new flu vaccine could be on the market, while Moderna CEO Stéphane Bancel said earlier this summer that he expects its candidate to be commercially available “over the next two to three years.”
In late August, Moderna filed suit against Pfizer for its use of mRNA technology, which paints an uneasy backdrop as they work to prove efficacy in other mRNA vaccines.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
